Evidence map›Paper›PMID 29924938›Full record

ArticleAmerican journal of respiratory cell and molecular biology2018

Discoidin Domain Receptor 2, a Potential Therapeutic Target in Lung Fibrosis.

Corina M Borza, Ambra Pozzi, Erin J Plosa

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Comprehensive analysis of the effects ofFrontiers in cell and developmental biology · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Corina M Borza1 Department of Medicine Vanderbilt University Medical Center Nashville, Tennessee.
Ambra Pozzi2 Veterans Affairs Hospitals Nashville, Tennessee and.
Erin J Plosa3 Department of Pediatrics Vanderbilt University Medical Center Nashville, Tennessee.
Vanderbilt University Medical Center · USDepartment of Veterans Affairs · AU

Funding

Vanderbilt O'Brien Kidney Center - Core D - Clinical and Translational CoreP30DK114809 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, MATTHEW H · 2017 to 2021
$5.9M
Matrix receptors in chronic kidney diseaseR01DK119212 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BORZA, CORINA MARILENA, POZZI, AMBRA · 2018 to 2022
$1.7M
Integrin/TGF-beta Axis in Tubulointerstitial FibrosisR01DK095761 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI POZZI, AMBRA · 2013 to 2016
$1.4M
Mechanisms of sex specific differences in neonatal hyperoxic lung injuryK08HL127103 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LINGAPPAN, KRITHIKA · 2015 to 2019
$816k
Beta 1 Integrin in the LungK08HL127102 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PLOSA, ERIN J · 2015 to 2019
$708k
Role of Collagen Binding Receptors in GlomerulosclerosisI01BX002025 · VA · VETERANS HEALTH ADMINISTRATION · PI AMBRA POZZI · 2013 to 2026
–
BLRD VA I01 BX002025NHLBI NIH HHS K08 HL127102NHLBI NIH HHS K08 HL127103NIDDK NIH HHS P30 DK114809NIDDK NIH HHS R01 DK095761NIDDK NIH HHS R01 DK119212
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Discoidin Domain Receptor 2ApoptosisFibroblastsProto-Oncogene Proteins c-aktSignal TransductionDiscoidin Domain Receptor 2Proto-Oncogene Proteins c-akt

Identifiers

PMID29924938
PMCPMC6189646
OpenAlexW2808900756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.